MSFinals-2286
A 55-year-old man with a history of hypertension has a 10-year cardiovascular disease risk of 20%. Atorvastatin 20 mg is prescribed, and liver function tests are conducted before starting treatment:
Bilirubin 10 µmol/l (3 – 17 µmol/l)
ALP 96 u/l (30 – 150 u/l)
ALT 40 u/l (10 – 45 u/l)
Gamma-GT 28 u/l (10 – 40 u/l)
After three months, the LFTs are repeated:
Bilirubin 12 µmol/l (3 – 17 µmol/l)
ALP 107 u/l (30 – 150 u/l)
ALT 104 u/l (10 – 45 u/l)
Gamma-GT 76 u/l (10 – 40 u/l)
What is the best course of action to take?